Status:
TERMINATED
Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery
Lead Sponsor:
St. Olavs Hospital
Conditions:
Hemorrhage
Postoperative Blood Loss
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Some patients undergoing cardiac surgery develop excessive postoperative bleeding. Cardiopulmonary bypass causes platelet dysfunction. Several studies have documented the ability of desmopressin to re...
Eligibility Criteria
Inclusion
- Patients above 18 years of age scheduled for cardiac surgery
- Excessive postoperative bleeding, more than 250 ml for one hour, or more than 150ml for two hours during the first four hours
Exclusion
- Patients younger than 18 years of age
- Patients with a medical condition known to influence the hemostatic system
- Patients treated with clopidogrel or systemic steroids during the last week before surgery
- Patients with INR above 1.5
- Patients who are not able to give written informed concent
- Unstable patients who need other transfusion limits than in this study
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00885924
Start Date
March 1 2009
End Date
February 1 2012
Last Update
April 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
StOlavs Hopital
Trondheim, Trondheim, Norway, 7018